Everything below concerns WADA Prohibited List. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-09-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common for reference-grade material. |
| Solubility | Low in water | Dissolves in DMSO and some organic solvents. |
| Typical storage | -20 °C, desiccated | Protect from light and moisture. |
| Analytical method | LC-MS/MS | Used for trace detection in biological matrices. |
| Purity assessment | HPLC with UV detection | Often combined with NMR and mass spectrometry. |
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
"The fibrous variant of Hashimoto's thyroiditis" (1974, with Austin L. Vickery Jr.) "Thymoma in a 12-year-old boy" (1976, with Jane Chatten) "Urinary Ultrastructural Findings in Fabry Disease" (1977, with Patricia J. Lyons) "Examination of Sputum in Legionnaire's Disease" (1978) "Legionnaires' disease: structural characteristics of the organism" (1978, with Philip Nash) "Leydig cell tumors of the testis" (1979, with I. Damjanov and M. A. Jewett) "Ultrastructural Features of Respiratory Cilia in Cystic Fibrosis" (1980, with Douglas S. Holsclaw Jr.) "Postinflammatory pseudotumors of the lung: fibrous histiocytoma and related lesions" (1980, with E. E. Schwartz and G. A. Mandell) "Tolmetin: Association With Reversible Renal Failure and Acute Interstitial Nephritis" (1981, with Ralph Capaldo, Erich A. Everts, and John G. DiGregorio) "Pleomorphism of Legionella pneumophila" (1984, with Shahab Hashemi, Kristy R. Brown, William A. Habib, and Jay M. Hammel) "Cilia in the Human Kidney" (1984, with Joseph J. Morgan) Legionellosis (1985) "Microscopic Nephrocalcinosis in Cystic Fibrosis" (1988, with Leslie J. Krueger and Bonita L. Falkner) "A Self-Limited Febrile Illness Produced in Guinea Pigs Associated With Oral Administration of Legionella pneumophila" (1988, with Jay M. Hammel, Joseph P. Matus, Ronald Poropatich, and Julian Katz) "Diagnostic value of electron microscopy on paraffin-embedded cytologic material" (1993, with Nancy A. Young and Sonya Naryshkin)
=== Biosynthesis === Phalloidin is a bicyclic heptapeptide containing an unusual cysteine-tryptophan linkage. The gene coding for synthesis of phalloidin is part of the MSDIN family in the Death Cap mushroom and codes for a 34 amino acid propeptide. A proline residue flanks the seven-residue region that will later become phalloidin. After translation, the peptide must be proteolyticly excised, cyclized, hydroxylated, Trp-Cys cross-linked to form tryptathionine, and epimerized to form a D-Thr. The order and exact biochemical mechanism for these steps is not yet fully understood. The current belief is that the necessary biosynthetic genes are clustered near the MSDIN genes. The first post-translational modification of the 34-mer is proteolytic cleavage via a prolyl oligopeptidase (POP) to remove the 10-amino acid "leader" peptide. The POP then cyclizes the heptapeptide Ala-Trp-Leu-Ala-Thr-Cys-Pro by transpeptidation between amino acid 1 (Ala) and amino acid 7 (Pro). It is believed that the formation of tryptathionine through Trp-Cys cross-linking occurs next and is carried out by a different enzyme.
In 2006, nineteen African countries signed the "Accra Declaration" calling for a total ivory trade ban, and twenty range states attended a meeting in Kenya calling for a 20-year moratorium in 2007. Methods of obtaining ivory can be divided into:
Sources: en.wikipedia.org
Not all earthworms become two worms when cut in half. Only a limited number of earthworm species are capable of anterior regeneration. Applying urine to jellyfish stings does not relieve pain and may make the pain worse. The best immediate treatment for jellyfish stings is to rinse them in salt water. For some kinds of jellyfish stings, adding vinegar helps.
A bifid or bifurcated uvula is a split or cleft uvula. Newborns with cleft palate often also have a split uvula. The bifid uvula results from incomplete fusion of the palatine shelves but it is considered only a slight form of clefting. Bifid uvulas have less muscle in them than a normal uvula, which may cause recurring problems with middle ear infections. While swallowing, the soft palate is pushed backwards, preventing food and drink from entering the nasal cavity. When the soft palate fails to close against the back of the throat during swallowing, food and liquid may pass into the nasal cavity. Splitting of the uvula occurs infrequently but is the most common form of mouth and nose area cleavage among newborns. Bifid uvula occurs in about 2% of the general population, although some populations may have a high incidence, such as Native Americans who have a 10% rate. Bifid uvula is a common symptom of the rare genetic syndrome Loeys–Dietz syndrome, which is associated with an increased risk of aortic aneurysm.
== Six-membered heterocyclic amines == The structure of pyridine is similar to that of benzene except that a nitrogen atom replaces one carbon atom. Pyridine is used as a flavoring agent. The pyridine ring is part of two B vitamins: niacin and pyridoxine. Niacin, also called nicotinic acid, is found in most organisms. Via metabolism, it becomes nicotinamide adenine dinucleotide NAD, a coenzyme which is involved in oxidation and reduction in metabolic cells. A deficiency of niacin leads to a disease called pellagra. Pyridoxine or vitamin B6, it becomes a major compound in the metabolism of amino acids. Pyrimidine is a heterocyclic amine that contains two nitrogen atoms in an unsaturated six-membered ring. An example of a molecule that contains pyrimidine is thiamine, which is also known as vitamin B1. Thiamine deficiency produces beriberi. Pyrimidine is a component of the nucleobases cytosine, uracil, and thymine. The other two nucleobases, adenine and guanine, are also heterocyclic amines called purines; they are composed of a fused pyrimidine and imidazole.
=== Conciliation Service === The United States Conciliation Service, which had provided mediation for labor disputes as part of Department of Labor, was removed from that department and reconstituted as an independent agency, the Federal Mediation and Conciliation Service (United States). This was done in part because industry forces thought the existing service had been too "partial" to labor.
Sources: en.wikipedia.org
=== Disappearance === On 4 March 1998, at around 2:00 PM, Mendonça took his bicycle and cycled to his mother's workplace, located near the family home. He had asked his mother for permission to spend the afternoon riding in a car "with his friend Afonso" (Afonso Dias), a 22-year-old lorry driver. Mendonça's mother denied the request, and told him to go play in an abandoned lot outside her office.
In the 20th century, as it spread to the United States and Western countries, spiritual elements of acupuncture that conflicted with scientific knowledge were sometimes abandoned in favor of simply tapping needles into acupuncture points.
== Further reading == Rogers, Andrew W (1979). Techniques of Autoradiography (3rd ed.). New York: Elsevier North Holland. ISBN 978-0-444-80063-3. "Patent US4101780 Treating silver with a radioactive sulfur compound such as thiourea or derivatives". Google Patents. Retrieved 26 June 2014.
Sources: en.wikipedia.org
LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.
Reference material is usually kept cold, dry, and protected from light. Frozen aliquots reduce repeated freeze-thaw cycles.
No approved pharmaceutical product exists, so manufacturing and quality controls are not standardized. Products may contain different compounds or impurities.
Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.